P

Puma Biotechnology
D

PBYI

3.04000
USD
0.09
(3.05%)
Market Open
Volume
8,251
EPS
0
Div Yield
0
P/E
16
Market Cap
149,102,038
OverviewSignalsIdeasNews
Related Instruments
    A
    ALKS
    -0.440
    (-1.61%)
    26.860 USD
    E
    ESPR
    -0.13000
    (-5.62%)
    2.18500 USD
    I
    IMGN
    0
    (0%)
    0.000000 USD
    I
    INCY
    -0.680
    (-1.05%)
    64.390 USD
    J
    JAZZ
    3.940
    (3.57%)
    114.330 USD
    M
    MDGL
    -6.22
    (-2.18%)
    278.97 USD
    N
    NKTR
    -0.10000
    (-7.38%)
    1.25500 USD
    P
    PCRX
    0.090
    (0.44%)
    20.750 USD
    S
    SRPT
    1.650
    (1.16%)
    144.000 USD
News

Title: Puma Biotechnology

Sector: Healthcare
Industry: Biotechnology
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.